Petrus Trust Company’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Petrus Trust Company's JAZZ Position: Q4 2025 in Review
Petrus Trust Company sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 2,380 shares — an estimated $314K sold.
Petrus Trust Company first reported a position in JAZZ in Q3 2018 and held it in 15 quarters. The position peaked at $779K in Q1 2025. 576 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.
- Petrus Trust Company reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Petrus Trust Company sold 2,380 Jazz Pharmaceuticals shares in Q4 2025, an estimated $314K.
- Petrus Trust Company first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 15 quarters.
- Petrus Trust Company's Jazz Pharmaceuticals position peaked at $779K in Q1 2025.
- 576 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.
Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.